Skeleton and Joint Degeneration with Aging
骨骼和关节随衰老而退化
基本信息
- 批准号:10556410
- 负责人:
- 金额:$ 184.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-15 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAgeAgingArthralgiaArthritisAxonBasic ScienceBiometryBone MarrowCause of DeathCell AgingCellsChronic DiseaseCompensationConsensusDegenerative polyarthritisDevelopmentDisciplineDiseaseExperimental ModelsFunctional disorderFutureHistologyHumanIndividualInjectionsIntervertebral disc structureJointsLeadLife ExpectancyLongevityLow Back PainMacrophageModelingMorphologyMusNTN1 geneNerveOsteoclastsPTH genePainPathogenesisPatientsPersonsPhysiciansPhysiologic OssificationPhysiologicalPlayPopulationPorosityPositioning AttributeProcessProgram Research Project GrantsQuality of lifeReportingResearchResearch PersonnelRiskRisk FactorsRoleScientistSclerosisSecretory CellSensorySignal TransductionSkeletonSpinalTherapeuticTrainingTransforming Growth FactorsTraumatic ArthropathyUnited StatesUniversitiesVertebral columnWorkagedangiogenesisarticular cartilageburden of illnesscalcificationcostdisabilityfrailtyfunctional declineimprovedin vivoin vivo Modelinsightjoint destructionmechanical loadmedical attentionmedical schoolsmouse modelnerve supplynormal agingpain behaviorpain reductionplatelet-derived growth factor BBsenescenceskeletalspine bone structuresubchondral bonetherapeutic targettranslational applications
项目摘要
PROJECT SUMMARY/ABSTRACT
Decreased mobility significantly increases the risk of many chronic diseases leading to an acceleration of the
normal aging process. Skeletal degeneration, particularly of the spine and joints, are among the most prevalent
diseases leading to a decline in mobility and to frailty. Frailty, defined as a state of decreased physiologic reserve,
often develops with aging and influences a person’s ability to compensate for the additional burden of disease.
With development of frailty, the natural homeostatic reserve is reduced and the ability of the body to compensate
for perturbations is reduced. Degeneration of the spine and joints can substantially accelerate development of
frailty; however, the underlying pathophysiology of this degeneration in aging and the development and
progression of resulting low back pain (LBP) and osteoarthritis (OA) is not well understood. There is no disease-
modifying treatment for either, largely due to the lack in the understanding of pathophysiology of pain and the
unique cellular signaling changes among OA subtypes.
LBP commonly results from degeneration of the amphiarthrodial spinal joints, with pain correlating most strongly
with changes in vertebral endplate morphology. Degeneration of diarthrodial joints is a set of diverse processes
that are frequently lumped together under the umbrella term “osteoarthritis” but represent a heterogeneous
disease process. Osteoclasts (OC) in both vertebral endplates and subchondral bone undergo senescence
during aging to generate porous sclerotic endplates, uncoupled remodeling in subchondral bone, and senescent
OC secrete Netrin-1 to induce axonal extrusion and innervation that potentially lead to pain. Therefore, we
hypothesize that porous sclerotic endplates and uncoupled remodeling of subchondral bone by
senescent OC lead to skeletal joint degeneration and pain, severely limiting mobility and increasing
frailty to accelerate aging. In Project 1, we will investigate how endplate porosity with aging induces spinal
degeneration and sensory innervation to result in LBP. In Project 2, we will investigate the mechanism of the
translational application of intermittent parathyroid hormone injection (iPTH) – increased intervertebral disc (IVD)
volume to spinal degeneration and reduce endplate nerve innervation and LBP by remodeling of porous sclerotic
endplates. In Projects 3, we will characterize the mechanism of cellular senescence in two different subtypes of
OA: non-traumatic OA that is orchestrated by senescence of pre-OC. Together, these 3 projects, supported by
common Administrative and Biostatistics (Core A) and In Vivo Model and Histology (Core B) Cores, will result
in nuanced understanding of the pathophysiology of joint and spinal degeneration associated with aging and will
provide foundational mechanistic insights for potential therapeutic targets.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xu Cao其他文献
Xu Cao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xu Cao', 18)}}的其他基金
Sialylation of TLR2 Induces Osteoclast Fusion and Th 17 differentiation During Aging
TLR2 唾液酸化诱导衰老过程中破骨细胞融合和 Th 17 分化
- 批准号:
10430544 - 财政年份:2022
- 资助金额:
$ 184.37万 - 项目类别:
Sialylation of TLR2 Induces Osteoclast Fusion and Th 17 differentiation During Aging
TLR2 唾液酸化诱导衰老过程中破骨细胞融合和 Th 17 分化
- 批准号:
10650877 - 财政年份:2022
- 资助金额:
$ 184.37万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 184.37万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 184.37万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 184.37万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 184.37万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 184.37万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 184.37万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 184.37万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 184.37万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 184.37万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 184.37万 - 项目类别:
Research Grant














{{item.name}}会员




